Pigmentation Disorders Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2026

Jul 2018| TMR745A| Transparency

Report Highlights

Global Pigmentation Disorders Treatment Market: Overview
This report analyzes the global pigmentation disorders treatment market in terms of its current and future scenario. Rise in investment in R&D of novel advanced technologies, decrease in social taboos regarding pigmentation, increase in prevalence of pigmentation-related disorders, and rise in awareness about skin rejuvenation and treatment options are likely to drive the expansion of the global market during the forecast period. Pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, phototherapy, and laser therapy. These therapies are available in hospitals and aesthetic clinics & dermatology centers.

This report on the global pigmentation disorders treatment market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on product, application, and geography. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. In addition, the section comprises a competitive matrix and company profiles with a business overview to project the competitive landscape of the market. It also provides market attractiveness analysis in terms of geography and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global pigmentation disorders treatment market.

Global Pigmentation Disorders Treatment Market: Key Segments
Based on treatment, the global pigmentation disorders treatment market has been segmented into topical drugs, laser therapy, chemical peels, microdermabrasion, phototherapy, and others. In terms of disease indication, the market has been classified into hyperpigmentation (melasma, post-inflammatory hyperpigmentation, solar lentigines, and others) and hypopigmentation (vitiligo, albinism, and others). Based on end-user, the market has been categorized into hospitals, aesthetic clinics & dermatology centers, and others. The global pigmentation disorders treatment market has been analyzed based on increase in prevalence of pigmentation disorders, technology trends, expenditure on emerging technologies, and presence of key players in the region. Market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Pigmentation Disorders Treatment Market: Regional Outlook
In terms of geography, the global pigmentation disorders treatment market has been categorized into five major regions and key countries in these regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year. This report also covers the competitive scenario of the market in these regions.

Companies Mentioned in Report
The report profiles major players operating in the global pigmentation disorders treatment market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report are Bayer AG, ALLERGAN, Galderma S.A., SkinCeuticals, Pierre Fabre, EpiPharm AG, RXi Pharmaceuticals Corporation, Obagi Cosmeceuticals LLC, and Vivier Pharma.

The global pigmentation disorders treatment market has been segmented as follows:

Pigmentation Disorders Treatment Market, by Treatment
Topical Drugs
Laser Therapy
Chemical Peels
Microdermabrasion
Phototherapy
Others

Pigmentation Disorders Treatment Market, by Disease Indication
Hypopigmentation
Vitiligo
Albinism
Others
Hyperpigmentation
Melasma
Post-inflammatory Hyperpigmentation
Solar Lentigines
Others

Pigmentation Disorders Treatment Market, by End-user
Hospitals
Aesthetic Clinics & Dermatology Centers
Others

Pigmentation Disorders Treatment Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
Australia & New Zealand
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 2 : Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 3 : Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
  • Table 4 : Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
  • Table 5 : Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 6 : Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
  • Table 7 : North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country, 2016–2026
  • Table 8 : North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 9 : North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
  • Table 10 : North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
  • Table 11 : North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 12 : Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 13 : Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 14 : Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 15 : Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
  • Table 16 : Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
  • Table 17 : Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 18 : Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 19 : Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
  • Table 20 : Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 21 : Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by hypopigmentation, 2016–2026
  • Table 22 : Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
  • Table 23 : Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 24 : Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 25 : Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 26 : Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 27 : Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
  • Table 28 : Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
  • Table 29 : Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 30 : Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 31 : Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 32 : Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 33 : Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
  • Table 34 : Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
  • Table 35 : Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Figure 1 : Global Pigmentation Disorders Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 2 : Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 3 : Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017
  • Figure 4 : Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017
  • Figure 5 : Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017
  • Figure 6 : Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017
  • Figure 7 : Pigmentation Disorders Treatment Market Value Share, by End-user, 2017
  • Figure 8 : Pigmentation Disorders Treatment Market Value Share, by Region, 2017
  • Figure 9 : Global Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 10 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical Drugs, 2016–2026
  • Figure 11 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laser Therapy, 2016–2026
  • Figure 12 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Peels, 2016–2026
  • Figure 13 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microdermabrasion, 2016–2026
  • Figure 14 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Phototherapy, 2016–2026
  • Figure 15 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 16 : Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment, 2018–2026
  • Figure 17 : Global Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 18 : Global Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
  • Figure 19 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitiligo, 2016–2026
  • Figure 20 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Albinism, 2016–2026
  • Figure 21 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 22 : Global Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
  • Figure 23 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Melasma, 2016–2026
  • Figure 24 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-inflammatory Hyperpigmentation, 2016–2026
  • Figure 25 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Solar Lentigines, 2016–2026
  • Figure 26 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 27 : Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Disease Indication, 2018–2026
  • Figure 28 : Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Hypopigmentation, 2018–2026
  • Figure 29 : Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Hyperpigmentation, 2018–2026
  • Figure 30 : Global Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 31 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2016–2026
  • Figure 32 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aesthetic Clinics & Dermatology Centers, 2016–2026
  • Figure 33 : Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 34 : Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by End-user, 2018–2026
  • Figure 35 : Global Pigmentation Disorders Treatment Market Value Share, by Region, 2017 and 2026
  • Figure 36 : Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Region, 2018–2026
  • Figure 37 : North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 38 : North America Pigmentation Disorders Treatment Market Value Share, by Country, 2017 and 2026
  • Figure 39 : North America Pigmentation Disorders Treatment Market Attractiveness, by Country, 2018–2026
  • Figure 40 : North America Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 41 : North America Pigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
  • Figure 42 : North America Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 43 : North America Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 44 : North America Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
  • Figure 45 : North America Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
  • Figure 46 : North America Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
  • Figure 47 : North America Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
  • Figure 48 : North America Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 49 : North America Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 50 : Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 51 : Europe Pigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 52 : Europe Pigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 53 : Europe Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 54 : Europe Pigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
  • Figure 55 : Europe Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 56 : Europe Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 57 : Europe Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
  • Figure 58 : Europe Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
  • Figure 59 : Europe Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
  • Figure 60 : Europe Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
  • Figure 61 : Europe Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 62 : Europe Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 63 : Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 64 : Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 65 : Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 66 : Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 67 : Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
  • Figure 68 : Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 69 : Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 70 : Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
  • Figure 71 : Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
  • Figure 72 : Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
  • Figure 73 : Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
  • Figure 74 : Asia Pacific Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 75 : Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 76 : Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 77 : Latin America Pigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 78 : Latin America Pigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 79 : Latin America Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 80 : Latin America Pigmentation Disorders Treatment Market Attractiveness, by Treatment Type, 2018–2026
  • Figure 81 : Latin America Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 82 : Latin America Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 83 : Latin America Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
  • Figure 84 : Latin America Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
  • Figure 85 : Latin America Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
  • Figure 86 : Latin America Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
  • Figure 87 : Latin America Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 88 : Latin America Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 89 : Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 90 : Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 91 : Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 92 : Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 93 : Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
  • Figure 94 : Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 95 : Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 96 : Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
  • Figure 97 : Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
  • Figure 98 : Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
  • Figure 99 : Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
  • Figure 100 : Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 101 : Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report